Success Story: From Mucosal Immunology to EB-1A Approval After RFE For An Instructor From Italy
Client’s Testimonial:
"Thank you very much for your wonderful job!!!! I really appreciate what you have done to make this petition successful."
On August 4th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for an Instructor in the Field of Mucosal Immunology (Approval Notice).
General Field: Mucosal Immunology
Position at the Time of Case Filing: Instructor
Country of Origin: Italy
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 4th, 2026
Processing Time: 3 months, 22 days (Premium Processing Requested)
Case Summary:
North America Immigration Law Group (NAILG) represented an instructor whose work focuses on mucosal immunology, including immune regulation, metabolic pathways, antibody responses, inflammatory disease mechanisms, and cancer-related immune processes.
The client held a Ph.D. and had built specialized expertise in studying how metabolic pathways regulate immune responses in mucosal environments. At the time of filing, the client was working as an instructor at a U.S. medical school, where the client continued research on immune regulation and inflammatory disease mechanisms relevant to mucosal tissues and cancer biology. The petition documented a strong record of research achievement:
- 13 peer-reviewed journal articles, 6 abstracts, and 1 preprint
- 617 citations
- At least 10 completed peer reviews for respected journals
- Research support connected to the National Institutes of Health and the National Institute of Allergy and Infectious Diseases, as well as national private foundations.
8 recommendation letters from experts in the field, including 2 independent advisory opinions. One expert noted:
“Ensuring that [Client’s] work proceeds is thus not only important to the field but to the continued advancement of public health outcomes in the United States.”
NAILG also highlighted the extensive reliance on the client’s findings by independent researchers in the United States and abroad. Subsequent studies used the client’s work to advance research involving intestinal immune regulation, inflammatory disease mechanisms, immune cell differentiation, host–microbiome interactions, antibody responses, and cancer-related immune processes.
To demonstrate the client’s significance, the petition did not rely on publication and citation numbers alone. We explained how the client’s research clarified important mechanisms linking metabolism, immune regulation, microbiome activity, and disease progression. The petition also emphasized that the client’s work had provided a useful foundation for other researchers studying inflammatory disorders, immune-mediated diseases, colorectal cancer, and potential therapeutic strategies.
After USCIS issued an RFE, we responded by organizing the evidence around the EB-1A standard. The response connected the client’s publication record, citation impact, peer-review service, expert letters, funded research involvement, and continued U.S. research plans to show sustained acclaim and original scientific contributions of major significance.
This approval reflected the successful presentation of a mucosal immunology case grounded in strong publication impact, independent scholarly reliance, trusted peer-review service, expert recognition, and a continued research plan aimed at advancing immune regulation, inflammatory disease research, and cancer-related immunology in the United States.